Description
Generic Version of Trastuzumab Available in India?
Trastuzumab is the salt name for the drug sold under the brand name Trazumab. It is used to treat HER2-overexpressing new or metastatic (cancer that has spread) breast cancer. It can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel).
The new indications are:
HER2-Low Metastatic Breast Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with unresectable or metastatic HER2-Low breast cancer who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy.
Locally Advanced or Metastatic Gastric Cancer: Trastuzumab deruxtecan is now indicated for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received a prior trastuzumab based regimen.
Trastuzumab deruxtecan was earlier approved by Drug Controller General of India (DCGI), for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen.
Approved in May 2023 for the treatment of metastatic breast cancer. In March 2024, the Central Drugs Standard Control Organisation (CDSCO) approved the drug for two additional indications: HER2-low metastatic breast cancer and HER2-positive gastric cancer.
Will this product be accessible across all regions of India?
The product – Trazumab (Trastuzumab) Injection will be available across India on request. Trastuzumab is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
List of available brand-name drugs in India for Trastuzumab Injection
Branded Generic Drugs for Trastuzumab Injection: Biceltis | Canmab | Eleftha | Herclon | Hermab | Hersima Hertraz | Hervycta | Trasturel | Trazumab | Trumab | Ujvira
NEWS / UPDATES
- Aurobindo Pharma secures marketing authorisation for Trastuzumab biosimilar in India.
- AstraZeneca India receives CDSCO approval for sale, distribution of Trastuzumab.
- Trastuzumab Biosimilar, Hervycta, Launches in India.
- India’s first US FDA approved Biosimilar Trastuzumab brings new hope to patients.
- Generic Herceptin Approved in India.
- Roche-Launches-2-In-1-Biotech-Drug-For-Breast-Cancer-In-India.
- Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India.
- Roche Pharma launches PHESGO in India for the treatment of HER-2 positive breast .
